Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UHRF1 | Q96T88 | 1/20 | 0.39 |
| ▸ | NUDT1 | P36639 | 5/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.32 |
| ▸ | NOS3 | P29474 | 2/20 | 0.31 |
| ▸ | NOS1 | P29475 | 2/20 | 0.31 |
| ▸ | NOS2 | P35228 | 2/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26212502 | 0.80 | ALDH1A1 (0.33) | NUDT1 | |
| SCHEMBL22403923 | 0.79 | UHRF1 (0.31) | UHRF1CYP1A2CYP2A6 | |
| SCHEMBL25908641 | 0.76 | UHRF1 (0.45) | UHRF1NUDT1CYP1A2CYP2A6RIPK1 | |
| SCHEMBL10496086 | 0.76 | NOS3 (0.47) | UHRF1CYP1A2CYP2A6NOS3NOS1 | |
| SCHEMBL19824289 | 0.74 | UHRF1 (0.41) | UHRF1CYP1A2CYP2A6NOS3NOS1 | |
| SCHEMBL21259587 | 0.74 | UHRF1 (0.46) | UHRF1CYP1A2CYP2A6NOS3NOS1 | |
| SCHEMBL11616480 | 0.74 | UHRF1 (0.46) | UHRF1CYP1A2CYP2A6NOS3NOS1 | |
| SCHEMBL25862832 | 0.74 | UHRF1 (0.41) | UHRF1CYP1A2CYP2A6NOS3NOS1 | |
| SCHEMBL18730286 | 0.73 | LDHA (0.46) | RIPK1 | |
| SCHEMBL25552277 | 0.73 | GABRP (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230025356-A1 | COMPOSITION, LAYER INCLUDING THE COMPOSITION, LIGHT-EMITTING DEVICE INCLUDING THE COMPOSITION, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230025356-A1 | COMPOSITION, LAYER INCLUDING THE COMPOSITION, LIGHT-EMITTING DEVICE INCLUDING THE COMPOSITION, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | LAGE3, ITK, TEC | UHRF1 4478/4885NUDT1 3640/4885CYP1A2 4013/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.